Mar 12, 2026 04:01PM
Mar 12, 2026 04:01PM
Mar 10, 2026 10:39PM
Mar 10, 2026 10:39PM
Mar 9, 2026 04:01PM
Mar 9, 2026 04:01PM
Jan 12, 2026 08:33AM Xenon Pharmaceuticals expects key drug trial results in March
Jan 12, 2026 08:30AM
Jan 9, 2026 07:33AM
Jan 5, 2026 08:30AM
Jan 7, 2025 08:30AM
Nov 30, 2024 10:00PM
Jan 3, 2024 08:30AM
Dec 4, 2023 04:16PM Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Nov 30, 2023 06:03AM
Nov 29, 2023 10:51PM
Nov 29, 2023 04:05PM
Nov 29, 2023 04:03PM
Jan 4, 2023 04:01PM
Jan 4, 2023 04:01PM
Jul 21, 2022 04:43AM UPDATE: JPMorgan Starts Xenon Pharmaceuticals (XENE) at Overweight, Adds to Analyst Focus List
Jun 27, 2022 02:11PM
Jun 27, 2022 02:11PM
Jun 23, 2022 09:24AM
Jun 23, 2022 05:55AM
Jun 22, 2022 10:27PM
Jun 22, 2022 10:27PM
Jun 22, 2022 04:02PM Xenon Pharmaceuticals (XENE) Announces Proposed Public Offering of Common Shares, Warrants
Jun 22, 2022 04:02PM
Jun 22, 2022 04:02PM
Oct 4, 2021 09:25AM
Jan 10, 2017 02:00PM
Sep 26, 2016 10:24AM

288,141 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All